Search

Showing "11155" results for ""

Happy families

Will a long life be a good one?

Are lubricants safe?

Insulin resistance impairs response to hepatitis C therapy for patients co-infected with HIV

HIV ‘test and treat’ strategy could have individual and public health benefits in Washington DC

Good early increases in CD4 count reduce mortality risk for malnourished HIV patients

NAM to launch a new version of its website aidsmap.com

Cotrimoxazole cuts mortality for symptomatic patients with HIV in areas with low malaria prevalence

Inflammation associated with increased mortality risk for patients with HIV, even when CD4 cell count high

Kidney disease increases mortality for women with AIDS starting HIV treatment

Atazanavir for children approved in European Union

Expanding coverage of HIV therapy is highly cost-effective, and could prevent many new infections

CD4 cell count below 500 associated with increased risk of CVD - implications for 'when to start' debate

UNAIDS calls for radical simplification of treatment to support HIV prevention

HIV cure efforts severely underfunded, US activists report

Towards more compassionate care for people with drug-resistant TB

Merck stops development of CCR5 inhibitor vicriviroc

Maraviroc potentially useful if neurological disease is present

Receive the latest HIV research and conference news

Showing "11155" results for ""

Happy families

Will a long life be a good one?

Are lubricants safe?

Insulin resistance impairs response to hepatitis C therapy for patients co-infected with HIV

HIV ‘test and treat’ strategy could have individual and public health benefits in Washington DC

Good early increases in CD4 count reduce mortality risk for malnourished HIV patients

NAM to launch a new version of its website aidsmap.com

Cotrimoxazole cuts mortality for symptomatic patients with HIV in areas with low malaria prevalence

Inflammation associated with increased mortality risk for patients with HIV, even when CD4 cell count high

Kidney disease increases mortality for women with AIDS starting HIV treatment

Atazanavir for children approved in European Union

Expanding coverage of HIV therapy is highly cost-effective, and could prevent many new infections

CD4 cell count below 500 associated with increased risk of CVD - implications for 'when to start' debate

UNAIDS calls for radical simplification of treatment to support HIV prevention

HIV cure efforts severely underfunded, US activists report

Towards more compassionate care for people with drug-resistant TB

Merck stops development of CCR5 inhibitor vicriviroc

Maraviroc potentially useful if neurological disease is present

Receive the latest HIV research and conference news